NDC 55801-116-01 - HYDRALAZINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55801-116
- Requested NDC
- 55801-116-01
- Package NDCs from labels
- 55801-116-01, 55801-116-02
- Manufacturer
- Appco Pharma LLC | Upsher-Smith Laboratories, LLC
- Effective date
- 2018-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDRALAZINE HYDROCHLORIDE - Appco Pharma LLC | Upsher-Smith Laboratories, LLC | Appco Pharma LLC | Upsher-Smith Laboratories, LLC | 2018-12-18 | Human Prescription Drug Label |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 921c8693-84c2-4313-a2a6-ab3be637d554 | 2016-07-14 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d9892176-d4a6-4edb-92b9-5f56243f3d22 | 2016-06-13 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Teva Pharmaceuticals USA, Inc. | ddbbdb09-3202-42d7-bbb0-08331dde2f54 | 2016-02-29 | Warnings, Adverse reactions | FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.